logo

For the Inventor, By the Inventor

Tucson, AZ, United States of America

Joe G N Garcia

This inventor holds 16 USPTO granted patents and 1 published patent application, primarily in Pulmonary Medicine. Top assignees: The University of Chicago, The University of Arizona, University of Illinois. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joe G N Garcia. Retrieved from https://idiyas.com/inventor/joe-g-n-garcia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Chicago, IL (US) (2013 - 2017)
  • Tucson, AZ (US) (2018 - 2023)

Company Filing History:

goldMedal8 out of 968 
 
The University of Chicago
 patents
silverMedal5 out of 1,062 
 
The University of Arizona
 patents
bronzeMedal3 out of 2,437 
 
University of Illinois
 patents
4. 2 out of 2 
 
Aqualung Therapeutics Corp.
 patents
5. 2 out of 1,963 
 
University of Pittsburgh
 patents
6. 1 out of 961 
 
The United States Government as Represented by the Department of Veterans Affairs
 patents
where one patent can have more than one assignee

Years Active: 2013-2023

Loading Chart...
Areas of Expertise:
Biomarkers
Pulmonary Fibrosis
Lung Injury
Nicotinamide Phosphoribosyltransferase
Opioid Antagonists
Pulmonary Arterial Hypertension
Cancer Characterization
Lung Inflammation
Endothelial Cell Proliferation
Inhibitors
Compositions
Methods
16 patents (USPTO):Explore Patents
1. 11733242 - Biomarkers and methods of use for radiation-induced lung injury (2023-08-22),
2. 11466099 - Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies (2022-10-11),
3. 11142586 - Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies (2021-10-12),
4. 10993936 - Method of treating one or more symptoms of pulmonary fibrosis by administering inhibitors of nicotinamide phosphoribotransferase (2021-05-04),
5. 10975167 - Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase (2021-04-13),
6. 10961582 - Biomarkers for assessing idiopathic pulmonary fibrosis (2021-03-30),
7. 10633710 - Methods for characterizing cancer (2020-04-28),
8. 10300036 - Compositions and methods for treating and preventing lung injury (2019-05-28),
9. 10036069 - Biomarkers for assessing idiopathic pulmonary fibrosis (2018-07-31),
10. 9717725 - Use of opioid antagonists (2017-08-01),
11. 9675602 - Use of opioid antagonists to attenuate endothelial cell proliferation and migration (2017-06-13),
12. 9662390 - Use of opioid antagonists to attenuate endothelial cell proliferation and migration (2017-05-30),
13. 9662325 - Use of opioid antagonists to attenuate endothelial cell proliferation and migration (2017-05-30),
14. 9409983 - Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases (2016-08-09),
15. 8524731 - Use of opioid antagonists to attenuate endothelial cell proliferation and migration (2013-09-03),

Title: Joe G N Garcia: Innovator in Radiation-Induced Lung Injury Research

Introduction

Joe G N Garcia is a prominent inventor based in Tucson, Arizona, known for his significant contributions to the field of biomedical research. With a total of 16 patents to his name, he has made remarkable strides in understanding and treating radiation-induced lung injury.

Latest Patents

One of his latest patents focuses on biomarkers and methods of use for radiation-induced lung injury. This patent outlines innovative methods for utilizing nicotinamide phosphoribosyltransferase (NAMPT) as a biomarker in diagnosing and monitoring radiation-induced lung injury (RILI). The method involves analyzing tissue or plasma samples from human subjects to detect NAMPT levels, where elevated levels indicate the presence of RILI. Additionally, he has developed anti-human NAMPT antibodies, which are crucial for treating inflammatory disorders associated with NAMPT.

Career Highlights

Throughout his career, Joe G N Garcia has worked with esteemed institutions such as the University of Chicago and the University of Arizona. His research has significantly advanced the understanding of biomarkers in medical diagnostics and treatment.

Collaborations

He has collaborated with notable colleagues, including Jonathan Moss and Mark Lingen, contributing to a rich exchange of ideas and research advancements in his field.

Conclusion

Joe G N Garcia's innovative work in the realm of radiation-induced lung injury and his extensive patent portfolio underscore his impact on biomedical research. His contributions continue to pave the way for advancements in medical diagnostics and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…